Literature DB >> 10525286

Failure of selenomethionine residues in albumin and immunoglobulin G to protect against peroxynitrite.

R J Hondal1, A K Motley, K E Hill, R F Burk.   

Abstract

Selenomethionine has been suggested to protect against peroxynitrite by quenching it in vivo. Selenomethionine is distributed randomly in the methionine pool. Albumin and IgG were purified from plasma of a human being before and after 28 days of supplementation with 400 microg selenium/day as selenomethionine. The albumin contained 1 selenium atom, presumably as selenomethionine, per 8000 methionine residues before supplementation and 1 per 2800 after supplementation. Although this ratio suggested that selenomethionine would not have as great an effect in quenching peroxynitrite as would methionine, direct testing of the albumin and IgG fractions was carried out to assess the ability of these proteins to prevent peroxynitrite oxidation of dihydrorhodamine 123 to rhodamine 123. The ability of the albumin preparations to resist nitration of tyrosine residues was also assessed. The high-selenomethionine preparations of the proteins had no greater effect in quenching the peroxynitrite than did the normal-selenomethionine preparations. These results do not support the proposal that selenomethionine in proteins contributes to in vivo protection against peroxynitrite. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525286     DOI: 10.1006/abbi.1999.1435

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

1.  Functional analysis of recombinant human serum albumin domains for pharmaceutical applications.

Authors:  Sadaharu Matsushita; Yu Isima; Victor Tuan Giam Chuang; Hiroshi Watanabe; Sumio Tanase; Tomu Maruyama; Masaki Otagiri
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

Review 2.  Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy.

Authors:  M S Petronek; J M Stolwijk; S D Murray; E J Steinbach; Y Zakharia; G R Buettner; D R Spitz; B G Allen
Journal:  Redox Biol       Date:  2021-01-16       Impact factor: 10.787

Review 3.  Understanding the Redox Biology of Selenium in the Search of Targeted Cancer Therapies.

Authors:  Jeffrey M Stolwijk; Rohan Garje; Jessica C Sieren; Garry R Buettner; Yousef Zakharia
Journal:  Antioxidants (Basel)       Date:  2020-05-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.